Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
0.6
-385.74%
Never
—
-100.00%
20%
—
5 Years
Score0.6
Net Growth-385.74%
Net TrendNever
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
Xenon Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 32M to $ 7M and net income went from -$ 28M to -$ 345M. Revenue increased in 1 of those 5 years; net income in 0.
Between 2015 and 2025, revenue declined from $ 15M to $ 7M and net income went from -$ 15M to -$ 345M. Revenue increased in 3 of those 10 years; net income in 1.
Xenon Pharmaceuticals Inc currently holds a 5-year HDB Score of 0.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 65.26 | — |
1 Year2025-08-12 | $ 35.99 | 81.33% |
5 Years2021-08-12 | $ 17.86 | 265.40% |
10 Years2016-08-12 | $ 7.99 | 8x |
All Time2014-11-05 | $ 10.50 | 6x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2014-11-05 |
|---|---|---|---|---|---|
| Price | $ 65.26 | $ 35.99 | $ 17.86 | $ 7.99 | $ 10.50 |
| Return | — | 81.33% | 265.40% | 8x | 6x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 383M | $ 1.09B |
| 2025 | $ 7M | -$ 345M | $ 548M |
| 2024 | $ 0.00 | -$ 234M | $ 626M |
| 2023 | $ 0.00 | -$ 182M | $ 638M |
| 2022 | $ 9M | -$ 125M | $ 592M |
| 2021 | $ 18M | -$ 78M | $ 551M |
| 2020 | $ 32M | -$ 28M | $ 176M |
| 2019 | $ 6M | -$ 41M | $ 141M |
| 2018 | $ 0.00 | -$ 34M | $ 119M |
| 2017 | $ 311K | -$ 30M | $ 43M |
| 2016 | $ 1M | -$ 22M | $ 64M |
| 2015 | $ 15M | -$ 15M | $ 58M |
| IPO2014 | $ 28M | $ 13M | $ 84M |
Explore beyond XENE
You're looking at Xenon Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
